Human immunoglobulins are transported to HCMV viral envelope by viral Fc gamma receptors-dependent and independent mechanisms.
HCMV neutralizing antibodies
gp34 (RL11)
gp68 (UL119)
gp95 (RL12)
human IgGs
human cytomegalovirus
viral Fcγ-binding proteins
Journal
Frontiers in microbiology
ISSN: 1664-302X
Titre abrégé: Front Microbiol
Pays: Switzerland
ID NLM: 101548977
Informations de publication
Date de publication:
2022
2022
Historique:
received:
23
11
2022
accepted:
20
12
2022
entrez:
2
2
2023
pubmed:
3
2
2023
medline:
3
2
2023
Statut:
epublish
Résumé
Human cytomegaloviruses (HCMVs) employ many different mechanisms to escape and subvert the host immune system, including expression of the viral IgG Fcγ receptors (vFcγRs)
Identifiants
pubmed: 36726564
doi: 10.3389/fmicb.2022.1106401
pmc: PMC9885202
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1106401Informations de copyright
Copyright © 2023 Vezzani, Pimazzoni, Ferranti, Calò, Monda, Amendola, Frigimelica, Maione, Cortese and Merola.
Déclaration de conflit d'intérêts
EF and DM are employed by GSK. DM and EF report ownership of GSK shares and/or restricted GSK shares. GV, SC, DA, and MC were PhD students sponsored by GSK vaccines. SP, RF, and GM were graduate students in an internship in GSK. MM is an employee of the University of Naples Federico II with a consultancy contract with GSK. The authors declare that this study was sponsored by GlaxoSmithKline Biologicals SA. The sponsor had the following involvement in the study: study design, collection, analysis, interpretation of data, writing of this article and decision to submit it for publication.
Références
J Virol. 2008 Apr;82(7):3490-9
pubmed: 18216124
Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):14976-81
pubmed: 14657367
J Virol. 1992 Jun;66(6):3643-51
pubmed: 1316474
Curr Protoc Microbiol. 2010 Aug;Chapter 14:Unit 14E.3
pubmed: 20812216
J Virol. 2019 Feb 5;93(4):
pubmed: 30487278
J Virol. 2000 Aug;74(15):6712-9
pubmed: 10888608
J Biol Chem. 2004 Apr 2;279(14):14184-93
pubmed: 14734541
Front Microbiol. 2021 May 07;12:660901
pubmed: 34025614
J Virol. 1991 Jun;65(6):3411-5
pubmed: 1851889
Mol Immunol. 2009 Nov;47(1):114-22
pubmed: 19297023
J Virol. 1989 Nov;63(11):4479-88
pubmed: 2552134
Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14223-8
pubmed: 14623981
Methods Mol Biol. 2010;634:421-30
pubmed: 20677001
J Virol. 2002 Sep;76(17):8596-608
pubmed: 12163579
J Virol. 2011 Jan;85(1):98-111
pubmed: 20962081
Curr Top Microbiol Immunol. 2008;325:417-70
pubmed: 18637519
J Virol. 2006 Apr;80(7):3167-79
pubmed: 16537585
Viruses. 2018 Aug 20;10(8):
pubmed: 30127257
Viruses. 2014 Jan 07;6(1):172-88
pubmed: 24402306
J Virol. 2005 Sep;79(18):11990-2001
pubmed: 16140775
Nat Rev Immunol. 2008 Jan;8(1):34-47
pubmed: 18064051
J Biol Chem. 2010 Oct 29;285(44):34250-8
pubmed: 20736173
Adv Exp Med Biol. 2012;738:256-76
pubmed: 22399384
J Virol. 1998 Jun;72(6):4571-9
pubmed: 9573220
J Gen Virol. 1977 Aug;36(2):345-9
pubmed: 197204
Microbiol Spectr. 2016 Dec;4(6):
pubmed: 28087938
Elife. 2021 Mar 16;10:
pubmed: 33724188
PLoS Biol. 2006 Jun;4(6):e148
pubmed: 16646632
J Virol. 2005 Jan;79(2):997-1007
pubmed: 15613328
J Clin Invest. 2010 Sep;120(9):3191-208
pubmed: 20679731
J Virol. 1997 May;71(5):4042-54
pubmed: 9094682
Sci Rep. 2018 Feb 27;8(1):3700
pubmed: 29487324
J Gen Virol. 1986 Jul;67 ( Pt 7):1475-8
pubmed: 3014057
PLoS Pathog. 2014 May 15;10(5):e1004131
pubmed: 24830376
Transpl Infect Dis. 2001;3 Suppl 2:6-13
pubmed: 11926753
J Virol. 2010 Jan;84(2):1005-13
pubmed: 19889756
PLoS Pathog. 2011 Aug;7(8):e1002172
pubmed: 21852946
PLoS Pathog. 2014 Mar 06;10(3):e1003961
pubmed: 24604090
J Virol. 2005 Nov;79(21):13362-72
pubmed: 16227258
Nat Rev Immunol. 2020 Feb;20(2):113-127
pubmed: 31666730
J Virol. 2016 Jan 06;90(6):3262-7
pubmed: 26739053
J Virol. 2007 Nov;81(21):11861-9
pubmed: 17715239
Cell. 2006 Oct 20;127(2):305-16
pubmed: 17055432
Antiviral Res. 1994 May;24(1):17-26
pubmed: 7944310
Immunology. 1992 Sep;77(1):109-15
pubmed: 1328043
Cell Host Microbe. 2011 Sep 15;10(3):197-209
pubmed: 21925108
J Virol. 2000 Mar;74(5):2278-87
pubmed: 10666258
Int J Mol Sci. 2022 May 28;23(11):
pubmed: 35682757
J Virol. 2004 Nov;78(22):12406-15
pubmed: 15507627
J Exp Med. 1977 Jul 1;146(1):201-17
pubmed: 406347
PLoS Pathog. 2012 Sep;8(9):e1002878
pubmed: 23028305
Science. 2017 Nov 17;358(6365):929-932
pubmed: 29097492
Front Immunol. 2019 Sep 06;10:2110
pubmed: 31555298
J Virol. 2004 Oct;78(20):10960-6
pubmed: 15452216
Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3937-42
pubmed: 9520471
J Virol. 1988 Apr;62(4):1347-54
pubmed: 2831396
J Virol. 2001 Nov;75(22):11218-21
pubmed: 11602761
Nat Rev Immunol. 2020 Oct;20(10):633-643
pubmed: 32782358
J Virol. 2011 Apr;85(7):3239-49
pubmed: 21228231
PLoS One. 2012;7(11):e50166
pubmed: 23226246
Antiviral Res. 2000 Aug;47(2):57-77
pubmed: 10996394
Curr Opin Virol. 2013 Feb;3(1):3-12
pubmed: 23352692
Cell. 2004 Dec 29;119(7):915-26
pubmed: 15620351
J Virol. 1994 Feb;68(2):834-45
pubmed: 8289387
EMBO J. 1994 Jul 1;13(13):2963-9
pubmed: 8039492
J Virol. 1991 Nov;65(11):6144-53
pubmed: 1717716
J Cell Biol. 1994 Aug;126(4):991-1004
pubmed: 8051216
Front Cell Infect Microbiol. 2020 Mar 31;10:130
pubmed: 32296651
Curr Opin Immunol. 2019 Aug;59:42-48
pubmed: 31003070
J Immunol. 1976 Mar;116(3):772-7
pubmed: 176272
J Virol. 1999 Jan;73(1):377-87
pubmed: 9847342